The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 study of the efficacy and safety of erdafitinib in patients (pts) with bacillus Calmette-Guérin (BCG)-unresponsive, high-risk non–muscle-invasive bladder cancer (HR-NMIBC) with FGFR3/2 alterations (alt) in THOR-2: Cohort 2 interim analysis results.
 
James W.F. Catto
Honoraria - Abbott Laboratories
Consulting or Advisory Role - AstraZeneca/MedImmune; Ferring; Janssen; Roche
Speakers' Bureau - ASCO; AstraZeneca/MedImmune; MSD Oncology; Nucleix; Roche
Research Funding - Roche/Genentech
Travel, Accommodations, Expenses - European Association of Urology
 
Ben Tran
Honoraria - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; Janssen-Cilag; Pfizer; Sanofi; Tolmar
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; IQvia; Janssen-Cilag; MSD Oncology; Novartis; Pfizer/EMD Serono; Pfizer/EMD Serono; Roche Molecular Diagnostics; Sanofi; Tolmar
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb; Genentech (Inst); Ipsen; Janssen-Cilag (Inst); Merck Sharp & Dohme; Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma
 
Viraj A. Master
Honoraria - Ethicon; Exelixis
 
Morgan Roupret
Consulting or Advisory Role - Arquer Diagnostics; GlaxoSmithKline; Intuitive Surgical; Ipsen; Janssen-Cilag; Lilly; MSD; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Coloplast
 
Geraldine Pignot
Honoraria - Astellas Pharma; Bayer; Bouchara Recordati; Bristol-Myers Squibb/Pfizer; Ipsen; Janssen-Cilag; Roche
Consulting or Advisory Role - Janssen-Cilag; MSD Oncology (Inst); Pfizer; Roche
Expert Testimony - Astellas Pharma; Bouchara Recordati; Janssen
Travel, Accommodations, Expenses - Astellas Pharma; Ferring; Ipsen; Janssen-Cilag; Pfizer
 
Andrea Tubaro
Consulting or Advisory Role - Bayer
Other Relationship - Janssen
 
Nobuaki Shimizu
Honoraria - Astellas Pharma; AstraZeneca; Takeda
 
Nikhil Vasdev
No Relationships to Disclose
 
Jürgen E. Gschwend
Honoraria - Bayer Schering Pharma; Bristol-Myers Squibb; Janssen-Cilag
Consulting or Advisory Role - Bayer Schering Pharma; Bristol-Myers Squibb; Janssen-Cilag
 
Yohann Loriot
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Immunomedics; Janssen; Janssen (Inst); Loxo/Lilly; MSD Oncology; MSD Oncology (Inst); Pfizer/EMD Serono; Roche; Seagen; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Basilea (Inst); BMS (Inst); Exelixis (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Nektar (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen
 
Hiroyuki Nishiyama
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Chugai Pharma; Janssen; MSD
Speakers' Bureau - Astellas Pharma; AstraZeneca; Chugai Pharma; MSD
Research Funding - Chugai Pharma; Ono Pharmaceutical
 
Joan Redorta
Consulting or Advisory Role - Arquer diagnostics; AstraZeneca; BMS; Combat Medical; Janssen
 
Siamak Daneshmand
Stock and Other Ownership Interests - Taris
Honoraria - Aduro Biotech; Allergan (I); Bristol-Myers Squibb; Ferring; Janssen; Johnson & Johnson; Olympus; pacific edge; Photocure; QED Therapeutics
Consulting or Advisory Role - Ferring; Photocure; QED Therapeutics; Taris
Research Funding - Photocure
Travel, Accommodations, Expenses - Photocure
 
Yuji Miura
Honoraria - Bristol-Myers Squibb Japan; Eisai; MSD; Ono Pharmaceutical; Takeda
Research Funding - MSD (Inst); Ono Pharmaceutical (Inst)
 
Vahid Naini
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Lauren Crow
Employment - Janssen
 
Spyros Triantos
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Mahadi Baig
Employment - Janssen
 
Gary D. Steinberg
Stock and Other Ownership Interests - CG Oncology; Epivax Therapeutics; Urogen pharma
Honoraria - Aduro Biotech; AstraZeneca; Bristol-Myers Squibb; CG Oncology; enGene; Epivax Oncology; fergene; Ferring; Fidia Farmaceutici S. p. A.; FKD Therapies; Janssen Oncology; MDxHealth; Merck; Pfizer; Photocure; Roche/Genentech; Seagen; Sesen Bio; Urogen pharma
Consulting or Advisory Role - Boston Scientific; CG Oncology; Fidia Farmaceutici S. p. A.; Heat Biologics; Imvax; MDxHealth; Merck; NanOlogy; Natera; Nonagen Bioscience; photocure; Roche/Genentech; Taris BioMedical; Verity Pharmaceuticals